Jörn Drappa, MD, PhD
Chief Medical Officer

Jörn serves as our Chief Medical Officer. Prior to joining Ventyx, he served as Executive Vice President, R&D at Horizon Therapeutics. Prior to Horizon’s acquisition of Viela Bio, he served as Head of R&D and Chief Medical Officer at Viela Bio. Prior to Viela Bio, he served as Vice President, Clinical Development at MedImmune/AstraZeneca, where he headed all clinical functions outside of oncology. Prior to MedImmune/AstraZeneca, he served as Senior Medical Director for inflammation and autoimmune diseases at Genentech. Earlier in his career, he served as a Medical Director for Amgen. Jorn received his medical and Ph.D. degrees from the University of Cologne in Germany.

    Email Alerts
    Contact IR
    RSS Feeds